Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP7822566B2 - Duzhong leaf powder and its manufacturing method - Google Patents
[go: Go Back, main page]

JP7822566B2 - Duzhong leaf powder and its manufacturing method - Google Patents

Duzhong leaf powder and its manufacturing method

Info

Publication number
JP7822566B2
JP7822566B2 JP2021178838A JP2021178838A JP7822566B2 JP 7822566 B2 JP7822566 B2 JP 7822566B2 JP 2021178838 A JP2021178838 A JP 2021178838A JP 2021178838 A JP2021178838 A JP 2021178838A JP 7822566 B2 JP7822566 B2 JP 7822566B2
Authority
JP
Japan
Prior art keywords
eucommia
exosomes
leaves
leaf powder
freeze
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021178838A
Other languages
Japanese (ja)
Other versions
JP2023067515A (en
Inventor
智恵子 安間
孝広 落谷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HEKIZANEN Co., Ltd.
Original Assignee
HEKIZANEN Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HEKIZANEN Co., Ltd. filed Critical HEKIZANEN Co., Ltd.
Priority to JP2021178838A priority Critical patent/JP7822566B2/en
Publication of JP2023067515A publication Critical patent/JP2023067515A/en
Priority to JP2025282138A priority patent/JP2026053633A/en
Application granted granted Critical
Publication of JP7822566B2 publication Critical patent/JP7822566B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Tea And Coffee (AREA)

Description

本発明は、杜仲葉の粉末状加工物及びその製造方法等に関する。 The present invention relates to a powdered processed product of Eucommia ulmoides leaves and a method for producing the same.

近年の研究により細胞間のコミュニケーションに細胞外小胞(Extracellularvesicles、EVs)が使用されているということが知られ、そのサイズや生物学的機能からエクソソーム、MV(microvesicles)などに分類され、中でも直径50~150nmの小胞はエクソソームと呼ばれ、近年生体内での機能の解明が急速に進んでいる。エクソソーム研究の中でも、がんとの関連は特に注目されているが、がん細胞は、がん細胞由来のエクソソームが20%多く放出されることが知られているため、がん組織においてエクソソームは重要なツールとして位置付けられている。また、エクソソームはがんがその兆候を示す前、初期の段階から放出されていることから、がんの早期発見マーカーとして、実用化に向けて研究がすすめられている。また逆に、間葉系幹細胞から産生されるエクソソームや植物由来のエクソソームには、がん抑制効果が見られ、研究対象として注目が集まっている。 Recent research has revealed that extracellular vesicles (EVs) are used for intercellular communication. They are classified into exosomes, microvesicles (MVs), and other types based on their size and biological function. Among these, vesicles with diameters of 50-150 nm are called exosomes, and in recent years, their function in the body has been rapidly elucidated. Among exosome research, the relationship with cancer has received particular attention. Because cancer cells are known to release 20% more exosomes than normal, exosomes are considered an important tool in cancer tissue. Furthermore, because exosomes are released in the early stages, before cancer symptoms appear, research is underway to utilize them as a marker for early cancer detection. Conversely, exosomes produced from mesenchymal stem cells and plant-derived exosomes have been shown to have cancer-suppressing effects, drawing attention as research subjects.

「エクソソーム」自体の発見は今から30年ほど前にさかのぼるが、発見当初は細胞の不要物的な存在としか認知されず、その機能や存在意義などは長い間、不明であった。ところが、2008年にエクソソーム内にmRNAやmiRNAを含む核酸物質が内包されて他の細胞へと受け渡されている可能性が示されるや否や、ここ数年の間に関連研究が一気に加速し、今日に至っている。 The discovery of "exosomes" dates back approximately 30 years ago, but initially they were simply recognized as waste products of cells, and their function and significance remained unknown for a long time. However, in 2008, it was suggested that exosomes may contain nucleic acid substances, including mRNA and miRNA, and be passed on to other cells. As soon as this was demonstrated, related research has accelerated rapidly in the last few years, continuing to this day.

近年、エクソソームを介して細胞外へ放出されているmiRNAの存在に着目し、非侵襲性で感度の高いバイオマーカーの確立を目指して、白血病や悪性リンパ腫など造血器腫瘍患者の血清中miRNAを用いた診断・予後マーカーの探索が行なわれてきた。miRNAは18-22塩基の小分子RNAの一種で、細胞内でmRNAと結合してその転写を制御することが知られている。この研究が始まった2008年頃は、血清を含む体液中(細胞外)にmiRNAが存在するメカニズムや意義についてはよくわかっていなかったが、最近、東京医科大学血液内科学分野および分子病理学分野の共同研究により、急性白血病、悪性リンパ腫、骨髄腫患者由来の血清中においてmiR-92aが著減することが見いだされ、次々と報告されている(例えば、非特許文献1参照)。 In recent years, attention has been focused on the presence of miRNA released extracellularly via exosomes, and efforts have been made to establish non-invasive, highly sensitive biomarkers by searching for diagnostic and prognostic markers using miRNA in the serum of patients with hematopoietic tumors, such as leukemia and malignant lymphoma. miRNAs are a type of small RNA consisting of 18-22 bases, and are known to bind to mRNA intracellularly and regulate its transcription. When this research began around 2008, the mechanism and significance of the presence of miRNA in body fluids (extracellular), including serum, was not well understood. However, recent collaborative research between the Departments of Hematology and Molecular Pathology at Tokyo Medical University has revealed a significant decrease in miR-92a in the serum of patients with acute leukemia, malignant lymphoma, and myeloma, and a number of other reports have been published (see, for example, Non-Patent Document 1).

最近では、「エクソソーム」が細胞の分化・老化や免疫系の制御などさまざまな生命現象に関与していることが明らかになり、今後も本研究は発展して行くことは間違いない。エクソソームは「細胞外小胞」の中の氷山の一角であり、まだ未解明の部分が多く残されている。バイオロジーから臨床研究まで、様々なアプローチで研究を展開されるであろうが、バイオロジーの分野において「エクソソーム」を多く含有している組成物は、研究を進める上からも必要であり求められている。 Recently, it has become clear that exosomes are involved in a variety of biological phenomena, including cell differentiation and aging, and immune system regulation, and there is no doubt that this research will continue to develop in the future. Exosomes are just the tip of the iceberg among extracellular vesicles, and many aspects remain unknown. Research will likely be conducted using a variety of approaches, from biology to clinical research, but in the field of biology, compositions containing large amounts of exosomes are necessary and sought after for advancing research.

杜仲葉は三大漢方薬の一つで、ゲニポシド酸、ユーコミシンA、アスペルロシドやポリフェノールを豊富に含有し栄養成分も多くきわめて有用な食品である。そのため杜仲葉全体を食せることが好ましいが、杜仲葉は、グッタベルカという固いゴム成分を含むため、粉砕が容易でなく、粒子が細かい均一なものが得られないという問題があった。また、杜仲葉に含まれる有用成分を効率よく抽出するためには、できるだけ温度を上げないで粉末化する技術が必要である。 Eucommia leaves are one of the three major traditional Chinese medicines, and are rich in geniposidic acid, eucomisin A, asperuloside, and polyphenols, making them an extremely useful food with many nutritional components. For this reason, it is preferable to eat the entire eucommia leaf; however, because eucommia leaves contain a hard rubber component called gutta verka, they are difficult to grind, and it is difficult to obtain fine, uniform particles. Furthermore, in order to efficiently extract the useful components contained in eucommia leaves, a technique is needed to powder them without raising the temperature as much as possible.

門田宰他、細胞外小胞・エクソソーム研究の最前線:臨床応用を目指して、日本薬理学雑誌、2017年、149巻3号、119~122頁Kadota Osamu et al., The forefront of extracellular vesicle and exosome research: Aiming for clinical application, Japanese Pharmacology Journal, 2017, Vol. 149, No. 3, pp. 119-122

植物由来のエクソソームは、植物に含有される割合が極めて少なく世界中でいろいろな植物が、試験されている。本発明は、植物由来のエクソソームを高い含有率で含む粉末状組成物及びその製造方法を見出すことを課題とする。 Plant-derived exosomes are found in extremely small amounts in plants, and various plants around the world have been tested. The objective of the present invention is to discover a powdered composition containing a high content of plant-derived exosomes and a method for producing the same.

前記の課題を解決するため、本発明者らは鋭意検討を行った結果、杜仲葉を乾燥及び粉砕したときに鮮やかな緑色を呈するような杜仲葉粉末の製造方法を検討する中で、杜仲葉由来のエクソソームを大量に含む杜仲葉粉末の製造方法を見出した。すなわち、本発明は以下の実施形態を含む。 In order to solve the above-mentioned problems, the inventors conducted extensive research and, while investigating a method for producing a eucommia leaf powder that would exhibit a vivid green color when dried and pulverized, discovered a method for producing eucommia leaf powder that contains a large amount of eucommia leaf-derived exosomes. Specifically, the present invention includes the following embodiments.

(1)杜仲葉由来のエクソソームを含む杜仲葉粉末であって、抽出可能なエクソソームの粒子数が少なくとも2.37×10個/mgであることを特徴とする杜仲葉粉末。
(2)マンセル表色系において、色相5GY~10G、明度5~8及び彩度6~10の範囲の緑色を呈する(1)に記載の杜仲葉粉末。
(3)杜仲生葉を50~70℃で加熱して発酵を阻止する加熱工程と、加熱処理した杜仲葉を、各辺の長さが1mm~3cmの矩形状となるように切断する切断工程と、切断された杜仲葉を30~60℃の熱風にて乾燥し、その水分含量を20%以下にする熱風乾燥工程と、
熱風乾燥後の杜仲葉を、-15~-25℃で予備凍結し、その後-70℃以下の温度で凍結乾燥する凍結乾燥工程と、凍結乾燥後の杜仲葉を、粉砕機を用いて粒子径1~40μmとなるように粉砕する粉砕工程と、を含む杜仲葉粉末の製造方法。
(4)発酵加熱工程において、杜仲生葉が65℃にて2分間維持される(3)に記載の製造方法。
(5)熱風乾燥後の杜仲葉の水分含量が、5~15%である(3)又は(4)に記載の製造方法。
(6)(3)~(5)のいずれかに記載の方法により得られた杜仲葉粉末を精製水、リン酸緩衝生理食塩水又はアルカリイオン水で抽出して抽出液を得る抽出工程と、この抽出液を超遠心分離して得られた沈殿からエクソソームを回収する工程と、を含み、杜仲葉粉末1mgから、少なくとも2.37×10個のエクソソームを回収しうることを特徴とする杜仲葉に由来するエクソソームの製造方法。
(1) A Duzhong leaf powder containing exosomes derived from Duzhong leaves, characterized in that the number of extractable exosome particles is at least 2.37 × 10 8 / mg.
(2) Eucommia leaf powder described in (1) exhibits a green color with a hue of 5GY to 10G, a brightness of 5 to 8, and a saturation of 6 to 10 in the Munsell color system.
(3) a heating step in which the raw Eucommia leaves are heated to 50-70°C to prevent fermentation; a cutting step in which the heat-treated Eucommia leaves are cut into rectangular shapes with sides of 1 mm-3 cm; and a hot air drying step in which the cut Eucommia leaves are dried with hot air at 30-60°C to reduce their moisture content to 20% or less.
The method for producing eucommia leaf powder includes a freeze-drying step in which the eucommia leaves after hot air drying are pre-freezed at -15 to -25°C and then freeze-dried at a temperature of -70°C or lower, and a crushing step in which the eucommia leaves after freeze-drying are crushed using a crusher to have a particle size of 1 to 40 μm.
(4) A manufacturing method described in (3), in which the fresh Eucommia leaves are maintained at 65°C for 2 minutes during the fermentation heating step.
(5) A manufacturing method described in (3) or (4), in which the moisture content of the eucommia leaves after hot air drying is 5 to 15%.
(6) A method for producing exosomes derived from Eucommia ulmoides leaves, comprising: an extraction step of extracting Eucommia ulmoides leaf powder obtained by the method according to any one of (3) to (5) with purified water, phosphate-buffered saline, or alkaline ionized water to obtain an extract; and a step of recovering exosomes from the precipitate obtained by ultracentrifugation of the extract, wherein at least 2.37 x 10 exosomes can be recovered from 1 mg of Eucommia ulmoides leaf powder.

本発明の杜仲葉粉末は、その製造工程で加熱による変性が極力抑えられているため、鮮やかな緑色を呈する。また、凍結乾燥工程により、ゲニポシド酸などの堅いゴム成分の組織が破壊されることにより、粒子が細かく、水に溶けやすく滑らかな粉体が得られる。そのため、この杜仲葉粉末に含まれるエクソソームの抽出が容易で、その含有量も多く、他の栄養成分等の消失もない杜仲葉粉末を提供することができる。 The Eucommia ulmoides leaf powder of the present invention exhibits a vibrant green color because denaturation due to heating is minimized during the manufacturing process. Furthermore, the freeze-drying process destroys the structure of hard rubber components such as geniposidic acid, resulting in a finely granulated, smooth powder that dissolves easily in water. Therefore, it is possible to provide Eucommia ulmoides leaf powder that is easy to extract the exosomes contained in this Eucommia ulmoides leaf powder, contains a high amount of exosomes, and does not lose other nutritional components.

図1は、本実施形態の杜仲葉粉末の製造方法の概要を説明する工程図である。FIG. 1 is a process diagram illustrating an outline of the method for producing Eucommia leaf powder of this embodiment. 図2は、本実施形態の杜仲葉粉末からエクソソームを製造する方法の概要を説明する工程図である。Figure 2 is a process diagram outlining the method for producing exosomes from Eucommia leaf powder of this embodiment. 図3は、本実施形態の杜仲葉粉末からミリQ水で抽出したエクソソームの粒子数及びその粒子径分布を測定した結果を示すチャート図である。FIG. 3 is a chart showing the results of measuring the particle number and particle size distribution of exosomes extracted from the Eucommia ulmoides leaf powder of this embodiment with Milli-Q water. 図4は、本実施形態の杜仲葉粉末からPBSで抽出したエクソソームの粒子数及びその粒子径分布を測定した結果を示すチャート図である。Figure 4 is a chart showing the results of measuring the particle number and particle size distribution of exosomes extracted with PBS from the Eucommia leaf powder of this embodiment.

次に、本発明の各実施形態について、図面を参照して説明する。なお、以下に説明する各実施形態は、特許請求の範囲に係る発明を限定するものではなく、また、各実施形態の中で説明されている諸要素及びその組み合わせの全てが本発明の解決手段に必須であるとは限らない。 Next, each embodiment of the present invention will be described with reference to the drawings. Note that the embodiments described below do not limit the invention as defined in the claims, and not all of the elements and combinations thereof described in each embodiment are necessarily essential to the solution of the present invention.

(杜仲葉粉末)
本発明の1つの実施形態に係る杜仲葉粉末は、杜仲葉由来のエクソソームを含み、抽出可能なエクソソームの粒子数が少なくとも2.37×10個/mgであることを特徴とする。この値は、本実施形態の杜仲葉粉末に含まれるエクソソームを水で抽出した際の個数である。一方、リン酸緩衝生理食塩水(PBS)で抽出したときには、杜仲葉粉末1mgあたり5.72×10個のエクソソームが抽出され、さらに、アルカリイオン水で抽出したときには、杜仲葉粉末1mgあたり2.85×10個のエクソソームを得ることができる。したがって、本実施形態の杜仲葉粉末に含まれる抽出可能なエクソソームの粒子数は、好ましくは、約5×10個/mg以上であり、より好ましくは、約1.0×10個/mg以上である。本実施形態の杜仲葉粉末に含まれるエクソソームの粒子数の上限は特に限定されるものではないが、通常は、1~10億個/mg程度であろう。
(Morium leaf powder)
According to one embodiment of the present invention, the Eucommia leaf powder contains exosomes derived from Eucommia leaves and is characterized in that the number of extractable exosome particles is at least 2.37 x 10 8 particles/mg. This value is the number of exosomes contained in the Eucommia leaf powder of this embodiment when extracted with water. On the other hand, when extracted with phosphate-buffered saline (PBS), 5.72 x 10 8 exosomes are extracted per 1 mg of Eucommia leaf powder, and when extracted with alkaline ionized water, 2.85 x 10 9 exosomes can be obtained per 1 mg of Eucommia leaf powder. Therefore, the number of extractable exosome particles contained in the Eucommia leaf powder of this embodiment is preferably at least about 5 x 10 8 particles/mg, and more preferably at least about 1.0 x 10 9 particles/mg. The upper limit of the number of exosome particles contained in the Eucommia leaf powder of this embodiment is not particularly limited, but is typically around 10 to 1 billion particles/mg.

エクソソームの個数及びその平均粒径は、当該技術分野における任意の測定方法で測定することができる。測定方法としては、例えば、電気抵抗ナノパルス法(qNANO)、ナノ粒子トラキング法を用いた、エクソソームが溶液中にある状態で観測する湿式の測定方法や、透過型電子顕微鏡でエクソソームの形態を保ったまま観測する乾式の測定方法がある。 The number of exosomes and their average particle size can be measured using any measurement method known in the art. Examples of measurement methods include wet measurement methods that observe exosomes in solution using electrical resistive nanopulse (qNANO) and nanoparticle tracking methods, and dry measurement methods that observe exosomes while maintaining their morphology using a transmission electron microscope.

他の側面において、本実施形態の杜仲葉粉末は、粉末状態において、あるいは水に溶かしたときに鮮やかな緑色を呈し、甘い杜仲茶として飲用することができる。典型的な実施形態では、この杜仲茶飲料の緑色は、マンセル表色系において、色相5GY~10G、明度5~8及び彩度6~10の範囲内である。 In another aspect, the Eucommia leaf powder of this embodiment exhibits a vivid green color when in powder form or dissolved in water, and can be consumed as sweet Eucommia tea. In a typical embodiment, the green color of this Eucommia tea beverage is within the range of hue 5GY to 10G, value 5 to 8, and saturation 6 to 10 on the Munsell color system.

ここで、マンセル表色系とは、色を表す3属性、色立方体に基づく色の数値表現の一種であり、色票は、円筒座標を用いて配列し、明度Vを縦軸、色相Hを円周方向に、彩度Cを半径方向に配列してなり、この色票を空間的に配列したものを色立方体という。色相H(Hue)は最初の2桁で示され、1桁目は0~10からなり2桁目のY(黄),YR(黄赤),R(赤)などの色相からの隔たり量を表す。次に明度V(Vlue)を0(完全暗黒)から10(完全純白)の範囲の数字で表し、最後に彩度C(Chroma)を0(無彩色)から始め鮮やかな色になるにしたがって数字が大きくなるように表す。なお、明度と彩度の数字の間は判別のために「/」(スラッシュ)が入っている。なお、マンセル表色系は、JIS Z 8721(1944)に基づき、測定される。 The Munsell color system is a type of numerical representation of color based on three attributes: a color cube. Color charts are arranged using cylindrical coordinates, with lightness (V) on the vertical axis, hue (H) on the circumferential axis, and saturation (C) on the radial axis. A spatial arrangement of these color charts is called a color cube. Hue (H) is represented by the first two digits. The first digit ranges from 0 to 10 and represents the deviation from the second digit's hue, such as Y (yellow), YR (yellow-red), or R (red). Next, lightness (V) is represented by a number ranging from 0 (completely dark) to 10 (completely pure white). Finally, chroma (C) is represented by a number starting from 0 (achromatic) and increasing in number as the color becomes more vivid. Note that a "/" (slash) is inserted between the lightness and saturation numbers for distinction. The Munsell color system is measured in accordance with JIS Z 8721 (1944).

(杜仲葉粉末の製造方法)
本発明の他の実施形態における杜仲葉粉末の製造方法は、例えば、図1に示す工程に基づいて製造することができる。具体的には、杜仲生葉を加熱する加熱工程S101と、加熱により発酵を阻止した杜仲葉を切断する切断工程S102と、切断された杜仲葉の水分含量を約20%まで低下させる熱風乾燥工程S103と、凍結乾燥工程S104と、凍結乾燥した杜仲葉を粉砕する粉砕工程S105と、を含む。以下、各工程について詳細に説明する。
(Method for producing Eucommia leaf powder)
In another embodiment of the present invention, the method for producing Eucommia leaf powder can be, for example, based on the steps shown in Figure 1. Specifically, the method includes a heating step S101 for heating fresh Eucommia leaves, a cutting step S102 for cutting the Eucommia leaves whose fermentation has been inhibited by heating, a hot air drying step S103 for reducing the moisture content of the cut Eucommia leaves to about 20%, a freeze-drying step S104, and a crushing step S105 for crushing the freeze-dried Eucommia leaves. Each step is described in detail below.

原料として使用する杜仲生葉は、収穫後、加熱乾燥処理に供される前の社仲葉を意味するものであり、栽培により生産されたものであっても、天然より生産されたものであってもよい。例えば、当年葉で落葉前の生葉、神奈川県内においては、例えば、4~10月、好ましくは5~8月、より好ましくは7~8月に採取した生葉を用いることができる。杜仲葉は、自己破壊をおこしやすく劣化が早い。さらに切断された杜仲葉は、切断と同時に劣化が急速に進む。そのため収穫された葉のままで加熱により速やかに発酵を阻止しなければならない。具体的には、早朝、杜仲生葉を傷がつかない様に収穫し、直ちに発酵を阻止するため、加熱工程S101では、50℃から70℃の環境下、好ましくは約65℃の温度で1~10分程度、好ましくは約5分間加熱する。加熱方法としては、特に限定されないが、例えば、350℃の高温に熱したヒーターから温風を送風するなどの方法を用いて行うことができる。加熱後は、0~5℃の冷風にて急速冷却して余熱をとることが、生成物である粉末中のエクソソームの高い含有量と、その鮮やかな緑色を維持する上で好ましい。 The raw material, Eucommia ulmoides leaves, refer to those harvested and not yet subjected to heat-drying. They may be cultivated or naturally grown. For example, current-year leaves before they fall off, harvested in Kanagawa Prefecture between April and October, preferably between May and August, and more preferably between July and August, can be used. Eucommia leaves are prone to self-destruction and deteriorate quickly. Furthermore, cut Eucommia leaves deteriorate rapidly upon cutting. Therefore, fermentation must be prevented immediately by heating the harvested leaves. Specifically, Eucommia ulmoides leaves are harvested early in the morning without damaging them. To prevent fermentation immediately, in the heating step S101, they are heated at 50°C to 70°C, preferably at approximately 65°C, for 1 to 10 minutes, preferably approximately 5 minutes. The heating method is not particularly limited, but can be, for example, by blowing hot air from a heater heated to 350°C. After heating, it is preferable to quickly cool the product with cold air at 0-5°C to remove residual heat, in order to maintain the high exosome content in the resulting powder and its vivid green color.

切断工程S102では、裁断機を用いて、加熱処理した杜仲葉を各辺の長さが1mm~3cmの矩形状となるように切断する。切断後の杜仲葉の大きさは、後工程の乾燥を容易にするためには、1cm四方以下が好ましく、より好ましくは、5mm四方以下である。 In the cutting process S102, a cutter is used to cut the heat-treated du zhong leaves into rectangular pieces with sides measuring 1 mm to 3 cm. To facilitate drying in the subsequent process, the size of the cut du zhong leaves is preferably 1 cm square or less, and more preferably 5 mm square or less.

熱風乾燥工程S103では、切断された杜仲葉を30~60℃の熱風にて乾燥し、その水分含量を20%以下にすることが好ましい。後続する凍結乾燥工程をより効率的に行うためには、熱風乾燥後の水分含量は約5~15%とすることがより好ましい。 In the hot air drying step S103, the cut Eucommia leaves are dried with hot air at 30-60°C, preferably reducing the moisture content to 20% or less. To more efficiently perform the subsequent freeze-drying step, it is more preferable to reduce the moisture content after hot air drying to approximately 5-15%.

凍結乾燥工程S104は、これを、熱風乾燥により水分含量の低下した杜仲葉を、-15~25℃の冷凍庫で10日間保管し、時間をかけてしっかりと予備凍結を行う。時間をかけて凍らせることで、杜仲葉内の水分による氷の球を、よりきめ細かに凍結することができる。これにより氷がきめ細かに製造されることにより細胞の破壊は細かくなる。さらにこれを、真空凍結乾燥機に入れ-70℃、好ましくは-80℃にて6時間凍結した。凍結した杜仲葉を-10℃にて、高真空下で6時間時間をかけゆっくりと昇華乾燥を行い乾燥(昇華)させた。一度乾燥させた杜仲葉を、同じく高真空下で、30℃の熱を加え、8時間、乾燥具合を高めることが好ましい。これにより水分の含有率を1%にすることができる。 In the freeze-drying process S104, the Eucommia leaves, whose moisture content has been reduced by hot air drying, are stored in a freezer at -15 to 25°C for 10 days, allowing them to be thoroughly pre-frozen over time. By freezing slowly, the ice balls formed by the moisture within the Eucommia leaves can be frozen more finely. This produces finely granular ice, resulting in finer cell destruction. The leaves are then placed in a vacuum freeze dryer and frozen at -70°C, preferably -80°C, for 6 hours. The frozen Eucommia leaves are then slowly sublimated and dried (sublimated) under high vacuum at -10°C for 6 hours. Once dried, the Eucommia leaves are preferably heated to 30°C under high vacuum for 8 hours to further dry them. This allows the moisture content to reach 1%.

粉砕工程S105は、温度を0℃から50℃以下に抑えた環境で気流式の粉砕機を使用して平均粒径1~40ミクロンの粉末を得ることができる。粉砕条件としては、35℃以下で行い、約10μm以下の粉体を得ることが好ましい。 In the pulverization step S105, an airflow pulverizer is used in an environment where the temperature is kept between 0°C and 50°C or less, resulting in powder with an average particle size of 1 to 40 microns. The pulverization conditions are preferably 35°C or less, to obtain powder with a particle size of approximately 10 μm or less.

(エクソソームの製造方法)
他の実施形態におけるエクソソームの製造方法は、上述した方法により得られた杜仲葉粉末を精製水、リン酸緩衝生理食塩水又はアルカリイオン水で抽出して抽出液を得る溶媒抽出工程S201と、この抽出液を超遠心分離して得られた沈殿からエクソソームを回収する超遠心分離/回収工程S202と、を含む。
(Exosome manufacturing method)
In another embodiment, the method for producing exosomes includes a solvent extraction step S201 in which the Eucommia leaf powder obtained by the above-described method is extracted with purified water, phosphate-buffered saline, or alkaline ionized water to obtain an extract, and an ultracentrifugation/recovery step S202 in which exosomes are recovered from the precipitate obtained by ultracentrifuging this extract.

溶媒抽出工程S201で用いる抽出溶媒としては、水又は水溶液であれば特に限定されないが、たとえば、精製水(ミリQ水)、リン酸緩衝生理食塩水(PBS)、アルカリイオン水などが挙げられる。 The extraction solvent used in the solvent extraction step S201 is not particularly limited as long as it is water or an aqueous solution, but examples include purified water (Milli-Q water), phosphate-buffered saline (PBS), alkaline ionized water, etc.

本明細書において、用語「アルカリイオン水」とは、電気分解を施して得られるアルカリイオンを含有する水のことであり、イオン整水器等を用いて、酸性水とともに別途生成される。このアルカリイオン水のpHとしては、pH8~11程度のアルカリイオン水を用いればよい。これにより、杜仲葉からのエクソソームをより効率的に抽出回収することができる。なお、アルカリイオン水のpH値の調整は、イオン整水器の電気分解の電流値を変化させることにより適宜行うことができる。 As used herein, the term "alkaline ionized water" refers to water containing alkaline ions obtained by electrolysis, and is produced separately from acidic water using an ionized water purifier or the like. The pH of this alkaline ionized water should be approximately pH 8 to 11. This allows for more efficient extraction and recovery of exosomes from Eucommia leaves. The pH value of the alkaline ionized water can be adjusted as needed by changing the electrolysis current value of the ionized water purifier.

超遠心分離/回収工程S202は、例示的な実施形態において、100000~200000×gで1~6時間スクロースクッション密度勾配を用いた超遠心分離及びイオジキサノール(iodixanol)密度勾配を用いた超遠心分離を含む一連の超遠心分離工程を通じて実施していてよい。密度勾配液としては、例えば、OptiPrepTM(オプティプレップ)多用途密度勾配遠心分離媒体などが市販されている。 In an exemplary embodiment, the ultracentrifugation/recovery step S202 may be carried out through a series of ultracentrifugation steps, including ultracentrifugation using a sucrose cushion density gradient at 100,000 to 200,000×g for 1 to 6 hours and ultracentrifugation using an iodixanol density gradient. Commercially available density gradient solutions include, for example, OptiPrep multi-purpose density gradient centrifugation media.

(作用効果)
後述する実施例で示すように、植物由来のエクソソームとして高い含有量を有することが知られているグレープフルーツ由来のエクソソームと比較しても、杜仲葉には約200倍多くのエクソソームが含まれることから、本実施形態の杜仲葉粉末は、杜仲葉由来のエクソソームに含まれるmiRNAやタンパク質などの生理活性物質の薬理作用がより強く発揮される可能性がある。また、杜仲葉由来のエクソソームを大量に調製し、薬物送達システム等の研究に用いる上で有利である。
(Action and effect)
As will be shown in the Examples below, compared to grapefruit-derived exosomes, which are known to have a high content of plant-derived exosomes, Eucommia leaves contain approximately 200 times more exosomes. Therefore, the Eucommia leaf powder of this embodiment may more potently exert the pharmacological effects of bioactive substances such as miRNA and proteins contained in Eucommia leaf-derived exosomes. Furthermore, Eucommia leaf-derived exosomes can be prepared in large quantities, which is advantageous for use in research on drug delivery systems, etc.

(実施例1)杜仲葉粉末の製造
杜仲生葉3kgに、350℃に熱したヒーターからの温風を、2分間送風して葉の表面が瞬時に65℃になるようにして発酵を阻止した。冷却した杜仲葉を、裁断機を用いて、葉の中央の太い葉脈に平行に3mmにカットしたあと、その短冊形の葉を、直角方向に3mmに、カットし、3mmの四角形の葉を得た。その後、細かく切断した杜仲葉を、45℃の熱風で20分間乾燥した。乾燥後の杜仲葉の水分含量を、赤外線水分計FD-610(株式会社ケット科学研究所製)で測定した結果、水分含有量は10%であった。これを、真空凍結乾燥を行うため-20℃の冷凍庫で10日間保管し杜仲葉を、時間をかけてしっかりと予備凍結を行った。
Example 1: Production of Eucommia Leaf Powder. 3 kg of fresh Eucommia leaves were exposed to hot air from a heater heated to 350°C for 2 minutes, instantly raising the leaf surface to 65°C to prevent fermentation. The cooled Eucommia leaves were cut into 3 mm strips parallel to the thick vein in the center of the leaf using a cutter, and then the strips were cut perpendicularly to 3 mm strips to obtain 3 mm square leaves. The finely cut Eucommia leaves were then dried with hot air at 45°C for 20 minutes. The moisture content of the dried Eucommia leaves was measured using an infrared moisture meter FD-610 (manufactured by Kett Electric Laboratory Co., Ltd.), and found to be 10%. These were then stored in a -20°C freezer for 10 days in preparation for vacuum freeze-drying, allowing the Eucommia leaves to be thoroughly pre-frozen over time.

細かく裁断し、予備凍結した杜仲葉を、凍結乾燥機(東京理科器株式会社、FD0780型)に入れ、―80℃に6時間保持した。続いて、―10℃にて高真空下で6時間かけて水分を蒸発させ、ゆっくりと凍結乾燥を行った。このようにして乾燥させた杜仲葉を、同じ高真空下で30℃の熱を加え、8時間処理して、乾燥具合を高めた。これにより、水分の含有率が1%にした杜仲乾燥葉を得た。 Finely chopped and pre-frozen Eucommia leaves were placed in a freeze dryer (Tokyo Rikaki Co., Ltd., Model FD0780) and kept at -80°C for 6 hours. The water was then evaporated under high vacuum at -10°C for 6 hours, followed by slow freeze-drying. The Eucommia leaves dried in this way were then heated to 30°C under the same high vacuum for 8 hours to further dry them. This resulted in dried Eucommia leaves with a moisture content of 1%.

凍結乾燥後の杜仲葉を、気流式の粉砕機を用い、温度を35℃以下にして粉砕し、粒子径が9μmの微紛体を得た。得られた粉末を、JIS Z 8721「色の表示方法-三属性による表示」に準拠した標準色票を用いてマンセル表色系で表記すると、色相5G、明度5~8及び彩度6~10の範囲の緑色を呈した。 The freeze-dried Eucommia leaves were pulverized in an airflow pulverizer at a temperature of 35°C or below, yielding a fine powder with a particle size of 9 μm. When expressed in the Munsell color system using a standard color chart in accordance with JIS Z 8721 "Color representation - representation by three attributes," the resulting powder exhibited a green hue of 5G, a brightness of 5-8, and a saturation of 6-10.

(実施例2)杜仲葉粉末からのエクソソームの抽出
実施例1で製造した杜仲葉粉末250mgを、それぞれ100mLの精製水(ミリQ水)、PBS及びアルカリイオン水に添加して、室温で2時間攪拌して完全に溶解した。さらに室温で1時間静置した後、各溶液の上清をとり、2000gにて10分間、高速遠心分離を行った。上清を回収し、0.22μmのフィルターでろ過して得られたろ液55mLを、100000×gにて1時間、超遠心分離した。超遠心分離により得られた沈殿を、120μLのPBSで懸濁し、ナノパーティクルトラッキングシステムを用いて粒子数を計測した。
Example 2: Extraction of exosomes from Eucommia ulmoides leaf powder. 250 mg of the Eucommia ulmoides leaf powder prepared in Example 1 was added to 100 mL of purified water (Milli-Q water), PBS, and alkaline ionized water, respectively, and stirred at room temperature for 2 hours to completely dissolve. After standing at room temperature for another hour, the supernatant of each solution was collected and centrifuged at high speed at 2,000 g for 10 minutes. The supernatant was collected and filtered through a 0.22 μm filter. 55 mL of the resulting filtrate was ultracentrifuged at 100,000 × g for 1 hour. The precipitate obtained by ultracentrifugation was suspended in 120 μL of PBS, and the particle count was measured using a nanoparticle tracking system.

PBSに懸濁した沈殿を、さらにPBSで希釈系を調製し、日本カンタム・デザイン株式会社製のナノ粒子解析システムNanoSight(ナノサイト)(LM10、ソフトウェアVer.2.03)で分析した。表1に示したように、測定した粒子数に希釈倍率を乗じ、超遠心分離により回収した溶液120μL中の粒子濃度、及び全粒子数を計算した。さらに、超遠心分離に用いたろ液55mL中の杜仲葉粉末の使用量から、杜仲葉1mgあたりの粒子数を計算した。 The precipitate suspended in PBS was further diluted with PBS and analyzed using the NanoSight nanoparticle analysis system (LM10, software version 2.03) manufactured by Japan Quantum Design Co., Ltd. As shown in Table 1, the measured particle count was multiplied by the dilution factor to calculate the particle concentration and total particle count in the 120 μL solution recovered by ultracentrifugation. Furthermore, the number of particles per 1 mg of Eucommia leaves was calculated from the amount of Eucommia leaf powder used in the 55 mL filtrate used in ultracentrifugation.

図3は、ミリQ水で抽出したエクソソームの粒子数及びその粒子径分布を測定した結果を示す。平均粒子径は、129.3nm、測定試料(150倍希釈)の濃度は、1.81×10個/mLであった。図4は、PBSで抽出したエクソソームの粒子数及びその粒子径分布を測定した結果を示す。平均粒子径は、131.9nm、測定試料(500倍希釈)の濃度は、1.31×10個/mLであった。これらの結果より、杜仲葉粉末1mgあたりに含まれる粒子数は、2.37×10個(溶媒MilliQ Water)、5.72×10個(溶媒PBS)及び2.85×10個(アルカリイオン水)であった。また、計算上、ティースプーン1杯(約1.5g)には、8.57×1011個(溶媒PBS)、3.55×1011個(溶媒MilliQ Water)及び4.275×1012個(アルカリイオン水)の粒子数のエクソソームが含まれると推測された。 Figure 3 shows the results of measuring the particle count and particle size distribution of exosomes extracted with Milli-Q water. The average particle size was 129.3 nm, and the concentration of the measurement sample (150-fold dilution) was 1.81 x 10 particles/mL. Figure 4 shows the results of measuring the particle count and particle size distribution of exosomes extracted with PBS. The average particle size was 131.9 nm, and the concentration of the measurement sample (500-fold dilution) was 1.31 x 10 particles/mL. From these results, the number of particles contained per mg of Eucommia leaf powder was 2.37 x 10 particles (solvent Milli-Q Water), 5.72 x 10 particles (solvent PBS), and 2.85 x 10 particles (solvent alkaline ionized water). Furthermore, it was calculated that one teaspoon (approximately 1.5 g) contains 8.57 × 10 11 particles (solvent: PBS), 3.55 × 10 11 particles (solvent: MilliQ Water), and 4.275 × 10 12 particles (alkaline ionized water).

(比較例1)
グレープフルーツ乾燥粉末を、実施例2と同様の方法で、精製水で抽出後、超遠心分離して得た沈殿からエクソソームを回収した。得られたエクソソーム溶液は、2×10個/mLであった。これに対し、同時に杜仲葉粉末から抽出、回収したエクソソーム溶液は、5×1011個/mLとなり、グレープフルーツの約250倍の量であった。

(Comparative Example 1)
Dried grapefruit powder was extracted with purified water using the same method as in Example 2, and exosomes were recovered from the precipitate obtained by ultracentrifugation. The resulting exosome solution had a concentration of 2 x 10 cells/mL. In contrast, the exosome solution extracted and recovered from Eucommia ulmoides leaf powder at the same time had a concentration of 5 x 10 cells/mL, approximately 250 times the amount of grapefruit.

Claims (1)

杜仲生葉を50~70℃で加熱して発酵を阻止する加熱工程と、
加熱処理した前記杜仲葉を、各辺の長さが1mm~3cmの矩形状となるように切断する切断工程と、
前記切断された杜仲葉を30~60℃の熱風にて乾燥し、その水分含量を20%以下にする熱風乾燥工程と、
前記熱風乾燥後の杜仲葉を、-15~-25℃で予備凍結し、その後-70℃以下の温度で凍結乾燥する凍結乾燥工程と、
前記凍結乾燥後の杜仲葉を、粉砕機を用いて粒子径1~40μmとなるように粉砕する粉砕工程と、
を含む方法により製造された杜仲葉粉末を、精製水、リン酸緩衝生理食塩水又はアルカリイオン水で抽出して抽出液を得る抽出工程と、
前記抽出液を超遠心分離して得られた沈殿からエクソソームを回収する工程と、
を含み、前記杜仲葉粉末1mgから、少なくとも2.37×10から2.85×10 のエクソソームを回収しうることを特徴とする杜仲葉に由来するエクソソームの製造方法。
A heating process in which the Eucommia leaves are heated to 50-70°C to prevent fermentation.
a cutting step of cutting the heat-treated Eucommia leaves into rectangular shapes with each side having a length of 1 mm to 3 cm;
a hot air drying step of drying the cut Eucommia leaves with hot air at 30 to 60°C to reduce the moisture content to 20% or less;
a freeze-drying step of pre-freezing the hot-air-dried Eucommia leaves at −15 to −25° C. and then freeze-drying them at a temperature of −70° C. or lower;
a grinding step of grinding the freeze-dried Eucommia leaves using a grinder to a particle size of 1 to 40 μm;
an extraction step of extracting the Eucommia leaf powder produced by the method comprising the steps of: extracting the Eucommia leaf powder with purified water, phosphate buffered saline, or alkaline ionized water to obtain an extract;
A step of recovering exosomes from the precipitate obtained by ultracentrifugation of the extract;
and capable of recovering at least 2.37 x 10 to 2.85 x 10 exosomes from 1 mg of the Eucommia leaf powder.
JP2021178838A 2021-11-01 2021-11-01 Duzhong leaf powder and its manufacturing method Active JP7822566B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021178838A JP7822566B2 (en) 2021-11-01 2021-11-01 Duzhong leaf powder and its manufacturing method
JP2025282138A JP2026053633A (en) 2021-11-01 2025-12-25 Eucommia ulmoides leaf powder and method for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2021178838A JP7822566B2 (en) 2021-11-01 2021-11-01 Duzhong leaf powder and its manufacturing method

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025282138A Division JP2026053633A (en) 2021-11-01 2025-12-25 Eucommia ulmoides leaf powder and method for producing the same

Publications (2)

Publication Number Publication Date
JP2023067515A JP2023067515A (en) 2023-05-16
JP7822566B2 true JP7822566B2 (en) 2026-03-03

Family

ID=86325664

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021178838A Active JP7822566B2 (en) 2021-11-01 2021-11-01 Duzhong leaf powder and its manufacturing method
JP2025282138A Pending JP2026053633A (en) 2021-11-01 2025-12-25 Eucommia ulmoides leaf powder and method for producing the same

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025282138A Pending JP2026053633A (en) 2021-11-01 2025-12-25 Eucommia ulmoides leaf powder and method for producing the same

Country Status (1)

Country Link
JP (2) JP7822566B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118236415B (en) * 2024-02-20 2024-09-17 广东医科大学附属医院 Application of eucommia ulmoides-derived exosome nano vesicles in preparation of anti-bone tumor drugs

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005289952A (en) 2004-03-31 2005-10-20 Kobayashi Pharmaceut Co Ltd Deodorant containing Tochu
JP2010136654A (en) 2008-12-10 2010-06-24 Hekizanen:Kk Green du-zhong tea leaf powder and process for producing the same
JP2021193070A (en) 2020-06-08 2021-12-23 有限会社 碧山園 Viral infection improving agent comprising exosome derived from eucommia leaf

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0884560A (en) * 1994-09-19 1996-04-02 Orijin Fuji Kk Manufacture of leaf powder of eucommia ulmoides

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005289952A (en) 2004-03-31 2005-10-20 Kobayashi Pharmaceut Co Ltd Deodorant containing Tochu
JP2010136654A (en) 2008-12-10 2010-06-24 Hekizanen:Kk Green du-zhong tea leaf powder and process for producing the same
JP2021193070A (en) 2020-06-08 2021-12-23 有限会社 碧山園 Viral infection improving agent comprising exosome derived from eucommia leaf

Also Published As

Publication number Publication date
JP2023067515A (en) 2023-05-16
JP2026053633A (en) 2026-03-25

Similar Documents

Publication Publication Date Title
JP2026053633A (en) Eucommia ulmoides leaf powder and method for producing the same
KR102528139B1 (en) Cosmetic composition containing Camellia Sinensis Leaf exosome and Avena Sativa(Oat) Kernel exosome
CN107197981B (en) A kind of purple bud instant green tea and preparation method thereof
KR20130001517A (en) Preparation method of functional tea containing okra seeds or okra seed extract
JP7715365B2 (en) Viral infection treatment containing exosomes derived from Eucommia leaves
CN111122729B (en) Application of tea product in stabilizing blood sugar, quality grading method and screening method
CN104323221B (en) Grifola frondosus dry product and preparation method thereof
CN102258099B (en) A kind of theabrownin of Zijuan Pu'er tea and its application
CN116459275B (en) Preparation method of high-content black garlic polysaccharide and application of high-content black garlic polysaccharide in anti-HBV (hepatitis B Virus) drugs
TWI828062B (en) Methods for producing exosomes, the exosomes produced and their applications
CN112245448B (en) The application of Lingxianxin glycosides in anti-colorectal cancer
JPH03228646A (en) Instant powdered tea for controlling aging and production thereof
CN114468285A (en) A kind of processing technology of Phellinus linteus mycelium freeze-dried powder
CN107375331A (en) A kind of extracting method of pilose antler
JP5739109B2 (en) Fig-derived anti-type I allergy agent and its manufacturing method
JP7423780B2 (en) Method for producing purified Salacia plant extract
RU2828363C1 (en) Tea production method
CN110585137B (en) A kind of preparation method of Magnolia officinalis alcohol extract solid dispersion
CN115944668B (en) New applications of mulberry leaf extract
JPH05168435A (en) Processed food of leaves and its production
JP4413510B2 (en) Agaricus polysaccharide protein composition by low temperature extraction and its production method
CN118021882A (en) A method for preparing plant extract
CN107260900A (en) A kind of safflower ultramicro decoction piece preparation method
CZ2009117A3 (en) Biotechnological preparation process of bovine haemoderivative and use of such bovine haemoderivative
JP2022127176A (en) Method for extracting pyrocatechol and coffee for drinking containing the pyrocatechol

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20241018

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20251029

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20251111

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251219

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260113

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260209

R150 Certificate of patent or registration of utility model

Ref document number: 7822566

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150